Hypersensitized candidates to kidney transplantation in Portugal

Detalhes bibliográficos
Autor(a) principal: Lima, Bruno A.
Data de Publicação: 2013
Outros Autores: Miguel, Mendes, Alves, Helena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.18/2097
Resumo: [ENG] The presence of donor specific anti-HLA antibodies is generally a contraindication for transplantation and nowadays the identification of these antibodies are part of most pre-transplantation evaluations. In Portugal, the implemented protocol for registration and maintenance of the active list for kidney transplant includes a complement -dependent cytotoxity (CDC) panel-reactive antibody (PRA) screening method, and Luminex technology for detecting and characterizing HLA alloantibodies. Under the current Portuguese kidney allocation system from deceased donors, implemented in August 2007, deceased donor kidneys are primarily allocated via ABO identical and time on dialysis with extra points to hyperimmunized patients, namely PRA CDC > 50%. Additional risk for the candidate or transplant organ can be represented by a proposed calculated PRA (cPRA) based upon unacceptable HLA antigens detected by Luminex to which the patient has been sensitized. These unacceptable HLA antigens used to generate cPRA represents a virtual crossmatch (XM). Sensitized patients are less likely to be matched with a suitable donor organ. Even after clearing the hurdle of procuring a living donor, it is still possible that this is not sufficient due to the likelihood of having an XM-positive. In such cases, and in the presence of incompatible blood type between recipients and their intended living donors, kidney paired donation (KPD) can provide an answer to this catch by facilitating exchanges between willing donors kidneys. A national Portuguese KPD programme, when realized, may prevent the current loss of a significant number of suitable living donors and reduce waiting list time for a deceased donor. An upgrade of a suggested point system in a Portuguese KPD programme will be the use of cPRA instead of the values of PRA CDC. In Portugal, the virtual XM approach just represents the optimization of an existent technique.
id RCAP_ce1763d4e61147da4d4292ff2062fe39
oai_identifier_str oai:repositorio.insa.pt:10400.18/2097
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Hypersensitized candidates to kidney transplantation in PortugalCandidatos hipersensibilizados a transplantação renal em PortugalTransplantação RenalPortugal[ENG] The presence of donor specific anti-HLA antibodies is generally a contraindication for transplantation and nowadays the identification of these antibodies are part of most pre-transplantation evaluations. In Portugal, the implemented protocol for registration and maintenance of the active list for kidney transplant includes a complement -dependent cytotoxity (CDC) panel-reactive antibody (PRA) screening method, and Luminex technology for detecting and characterizing HLA alloantibodies. Under the current Portuguese kidney allocation system from deceased donors, implemented in August 2007, deceased donor kidneys are primarily allocated via ABO identical and time on dialysis with extra points to hyperimmunized patients, namely PRA CDC > 50%. Additional risk for the candidate or transplant organ can be represented by a proposed calculated PRA (cPRA) based upon unacceptable HLA antigens detected by Luminex to which the patient has been sensitized. These unacceptable HLA antigens used to generate cPRA represents a virtual crossmatch (XM). Sensitized patients are less likely to be matched with a suitable donor organ. Even after clearing the hurdle of procuring a living donor, it is still possible that this is not sufficient due to the likelihood of having an XM-positive. In such cases, and in the presence of incompatible blood type between recipients and their intended living donors, kidney paired donation (KPD) can provide an answer to this catch by facilitating exchanges between willing donors kidneys. A national Portuguese KPD programme, when realized, may prevent the current loss of a significant number of suitable living donors and reduce waiting list time for a deceased donor. An upgrade of a suggested point system in a Portuguese KPD programme will be the use of cPRA instead of the values of PRA CDC. In Portugal, the virtual XM approach just represents the optimization of an existent technique.[PT] A presença de anticorpos anti-HLA específicos do dador é geralmente uma contraindicação para transplante e, hoje em dia, a identificação destes anticorpos é parte de muitos protocolos de avaliação pré--transplante. Em Portugal, o protocolo implementado para o registo e manutenção em lista activa para transplante de rim, inclui um método de pesquisa em painel reactivo de anticorpos (PRA) por citotoxicidade dependente do complemento (CDC) e a tecnologia Luminex para detectar e caracterizar aloanticorpos HLA. Segundo as actuais normas para a selecção do par dador-receptor em homotransplantação com rim de cadáver, implementadas em Agosto de 2007, a distribuição destes órgãos é prioritariamente isogrupal, contabilizando o tempo em diálise com pontos extra paras doentes imunizados, nomeadamente PRA CDC>50%. Um risco adicional para os candidatos a transplante de órgãos pode ser representado pelo proposto PRA calculado (cPRA), que tem por base antigénios HLA não aceitáveis, detectados por Luminex e para os quais os doentes estão sensibilizados. Estes antigénios HLA não aceitáveis usados para gerar o cPRA representam um crossmatch (XM) virtual. Os doentes sensibilizados têm uma menor probabilidade de encontrar um dador de órgãos admissível e mesmo depois de ultrapassada a barreira de encontrar um dador vivodisponível, é possível que isto não seja suficiente devido ao risco elevado de ter um XM positivo. Nestes casos e quando há incompatibilidade ABO entre um receptor e o seu potencial dador vivo, a troca de dadores vivos de rim (TDR) pode ser a resposta a este problema facilitando a consumação de transplantes compatíveis. Um programa nacional de TDR, quando implementado, pode evitar o actual desperdício de possíveis dadores vivos de rim e potencialmente reduzir o tempo de espera em lista para transplante com dador cadáver. Uma melhoria a um sugerido sistema de pontuação num programa Português de TDR será a utilização do cPRA em substituição dos valores de PRA CDC. Em Portugal, a abordagem de XM-virtual apenas representa a optimização de técnicas já existentes.Sociedade Portuguesa de NefrologiaRepositório Científico do Instituto Nacional de SaúdeLima, Bruno A.Miguel, MendesAlves, Helena2014-03-12T17:37:38Z2013-05-202013-05-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/2097engPort J Nephrol Hypert. 2013;27(2): 77-810872-0169info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:39:02Zoai:repositorio.insa.pt:10400.18/2097Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:37:04.074306Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Hypersensitized candidates to kidney transplantation in Portugal
Candidatos hipersensibilizados a transplantação renal em Portugal
title Hypersensitized candidates to kidney transplantation in Portugal
spellingShingle Hypersensitized candidates to kidney transplantation in Portugal
Lima, Bruno A.
Transplantação Renal
Portugal
title_short Hypersensitized candidates to kidney transplantation in Portugal
title_full Hypersensitized candidates to kidney transplantation in Portugal
title_fullStr Hypersensitized candidates to kidney transplantation in Portugal
title_full_unstemmed Hypersensitized candidates to kidney transplantation in Portugal
title_sort Hypersensitized candidates to kidney transplantation in Portugal
author Lima, Bruno A.
author_facet Lima, Bruno A.
Miguel, Mendes
Alves, Helena
author_role author
author2 Miguel, Mendes
Alves, Helena
author2_role author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Lima, Bruno A.
Miguel, Mendes
Alves, Helena
dc.subject.por.fl_str_mv Transplantação Renal
Portugal
topic Transplantação Renal
Portugal
description [ENG] The presence of donor specific anti-HLA antibodies is generally a contraindication for transplantation and nowadays the identification of these antibodies are part of most pre-transplantation evaluations. In Portugal, the implemented protocol for registration and maintenance of the active list for kidney transplant includes a complement -dependent cytotoxity (CDC) panel-reactive antibody (PRA) screening method, and Luminex technology for detecting and characterizing HLA alloantibodies. Under the current Portuguese kidney allocation system from deceased donors, implemented in August 2007, deceased donor kidneys are primarily allocated via ABO identical and time on dialysis with extra points to hyperimmunized patients, namely PRA CDC > 50%. Additional risk for the candidate or transplant organ can be represented by a proposed calculated PRA (cPRA) based upon unacceptable HLA antigens detected by Luminex to which the patient has been sensitized. These unacceptable HLA antigens used to generate cPRA represents a virtual crossmatch (XM). Sensitized patients are less likely to be matched with a suitable donor organ. Even after clearing the hurdle of procuring a living donor, it is still possible that this is not sufficient due to the likelihood of having an XM-positive. In such cases, and in the presence of incompatible blood type between recipients and their intended living donors, kidney paired donation (KPD) can provide an answer to this catch by facilitating exchanges between willing donors kidneys. A national Portuguese KPD programme, when realized, may prevent the current loss of a significant number of suitable living donors and reduce waiting list time for a deceased donor. An upgrade of a suggested point system in a Portuguese KPD programme will be the use of cPRA instead of the values of PRA CDC. In Portugal, the virtual XM approach just represents the optimization of an existent technique.
publishDate 2013
dc.date.none.fl_str_mv 2013-05-20
2013-05-20T00:00:00Z
2014-03-12T17:37:38Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/2097
url http://hdl.handle.net/10400.18/2097
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Port J Nephrol Hypert. 2013;27(2): 77-81
0872-0169
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132104353644544